annb0t
Top 20
Loading…
cdn.benzinga.com
Executives at GSK Plc (NYSE: GSK), Moderna Inc (NASDAQ: MRNA), and CSL Seqirus, owned by CSL Ltd (OTC: CSLLY), said they are developing or about to test sample human vaccines against bird flu as a precautionary measure against a future pandemic. Others, like Sanofi SA (NASDAQ: SNY), said they "stand ready" to begin production if ne...
>>> Read more: Large Vaccine Players Including GSK, Moderna Prepare For Bird Flu Vaccine 'Just In Case'